Live from the NIH registry
Studies recruiting near Kalamazoo right now
Top 25 of 104 recruiting studies, sorted by proximity — each links to its official registry page
Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
First Episode Psychosis
Phase 4
Interventional 300 participants sought
InterAct of Michigan — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Northwell Health
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Observational 5,000 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute LAO
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: SWOG Cancer Research Network
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
Pregnancy
N/A
Interventional 4,700 participants sought
Planned Parenthood - Kalamazoo — Kalamazoo, Michigan (1.2 mi)
· Sponsor: University of Michigan
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
WMU Homer Stryker MD School of Medicine — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Novo Nordisk A/S
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
B Acute Lymphoblastic Leukemia Associated With Down Syndrome, Down Syndrome
N/A
Observational 330 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Children's Oncology Group
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular
Phase 3
Interventional 750 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Children's Oncology Group
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma
N/A
Observational 800 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: University of Rochester
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Pancreatic Neoplasm
N/A
Observational 770 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Acute Treatment of Migraine
Phase 3
Interventional 600 participants sought
Wellnow Urgent Care and Research — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Pfizer
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Children's Oncology Group
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Children's Oncology Group
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: SWOG Cancer Research Network
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
Posttraumatic Stress Disorder, PTSD
N/A
Interventional 302 participants sought
Battle Creek VA — Battle Creek, Michigan (21.2 mi)
· Sponsor: The University of Texas Health Science Center at San Antonio
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Acute Ischemic Stroke
Phase 3
Interventional 404 participants sought
Bronson Methodist Hospital/Western Michigan University Homer Stryker M.D. School of Medicine — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Mercy Health Ohio
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Kalamazoo, Michigan (1.2 mi)
· Sponsor: DalCor Pharmaceuticals
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Ovarian Neoplasms, Fallopian Tube Neoplasms
Phase 3
Interventional 1,630 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Eli Lilly and Company
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)